7.40
price up icon3.06%   0.22
after-market Dopo l'orario di chiusura: 8.00 0.60 +8.11%
loading

Cadrenal Therapeutics Inc Azioni (CVKD) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
26.79%
2.7338
3.7343 3.928 2.46 2.4666
Operating Income/Loss
26.79%
-2.7338
-3.7343 -3.928 -2.46 -2.4666
Nonoperating Income/Loss
28.22%
0.0481
0.067 0.0826 0.0521 0.0736
Income/Loss From Continuing Operations Before Tax
26.77%
-2.6857
-3.6673 -3.8454 -2.4078 -2.393
Income/Loss From Continuing Operations After Tax
26.77%
-2.6857
-3.6673 -3.8454 -2.4078 -2.393
Net Income/Loss
26.77%
-2.6857
-3.6673 -3.8454 -2.4078 -2.393
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4.20%
2.044
1.9616 1.8441 1.104 16.01
Diluted Average Shares
4.20%
2.044
1.9616 1.8441 1.104 16.01
Basic Earnings Per Share
29.95%
-1.31
-1.87 -2.09 -2.18 -0.15
Diluted Earnings Per Share
29.95%
-1.31
-1.87 -2.09 -2.18 -0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):